CHiP co-authors new paper on Healthy Hearts in the Heartland (H3) study design
CHIP’s Abel Kho, Theresa Walunas, and Isabel Chung are co-authors of a new paper, “Design of healthy hearts in the heartland (H3): A practice-randomized, comparative effectiveness study,” that will be published in the August 2018 issue of Contemporary Clinical Trials. The Healthy Hearts in the Heartland (H3) study assesses the feasibility of implementing Point-of-Care (POC) and Population Management (PM) quality-improvement strategies to improve cardiovascular care in practices across Illinois, Indiana and Wisconsin. The strategies focus on the ABCS of clinical prevention of cardiovascular disease, which include: appropriate Aspirin therapy, Blood pressure control, Cholesterol management, and Smoking cessation.
While previous studies suggest that POC and PM strategies do work, little is known about how to implement these changes in small, independent practices. To address this gap in knowledge, H3 conducted a two-arm, practice-randomized, comparative effectiveness study in 226 primary care practices. This paper describes the study design and methodology.